Globus Rebound Driven by Double-Digit Spinal Implant Growth

Globus Medical logo

Globus Medical reported 3Q20 orthopedic revenue of USD $216.1 million, +10.1% vs. 3Q19. The company’s U.S. spinal implant business grew +17%, driven by new product introductions including the HEDRON line and new 3D-printed interbody spacers as well as pull through from ExcelusisGPS. Globus left some sales on the table due to lagging...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us